{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:53:54Z","timestamp":1781715234924,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011542","name":"Center for Clinical and Translational Science, Mayo Clinic","doi-asserted-by":"publisher","award":["UL1TR000135"],"award-info":[{"award-number":["UL1TR000135"]}],"id":[{"id":"10.13039\/100011542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mcpiqojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings: Innovations, Quality &amp; Outcomes"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.mayocpiqo.2026.100707","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T17:57:26Z","timestamp":1772474246000},"page":"100707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["When Refractory Is Not the End: Redefining Chronic Cough Through Tertiary Center Evaluation"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0225-3330","authenticated-orcid":false,"given":"Sumera R.","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek N.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"LeMahieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav","family":"Ahluwalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhor","family":"Ahluwalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinnera","family":"Jalagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue Ann","family":"Donlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiser","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mayocpiqo.2026.100707_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.rmed.2017.04.001","article-title":"Analysis of bronchial biopsies in chronic cough","volume":"127","author":"Macedo","year":"2017","journal-title":"Respir Med"},{"issue":"9621","key":"10.1016\/j.mayocpiqo.2026.100707_bib2","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0140-6736(08)60595-4","article-title":"Prevalence, pathogenesis, and causes of chronic cough","volume":"371","author":"Chung","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2026.100707_bib3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1164\/ajrccm\/141.3.640","article-title":"Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy","volume":"141","author":"Irwin","year":"1990","journal-title":"Am Rev Respir Dis"},{"issue":"4 Pt 1","key":"10.1016\/j.mayocpiqo.2026.100707_bib4","first-page":"413","article-title":"Chronic persistent cough in the adult: the spectrum and frequency of causes and successful outcome of specific therapy","volume":"123","author":"Irwin","year":"1981","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2026.100707_bib5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.resinv.2021.01.007","article-title":"The Japanese respiratory society guidelines for the management of cough and sputum (digest edition)","volume":"59","author":"Mukae","year":"2021","journal-title":"Respir Investig"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2026.100707_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4046\/trd.2021.0038","article-title":"Revised Korean Cough Guidelines, 2020: recommendations and summary statements","volume":"84","author":"Joo","year":"2021","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2026.100707_bib7","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01136-2019","article-title":"ERS guidelines on the diagnosis and treatment of chronic cough in adults and children","volume":"55","author":"Morice","year":"2020","journal-title":"Eur Respir J"},{"issue":"1 Suppl","key":"10.1016\/j.mayocpiqo.2026.100707_bib8","doi-asserted-by":"crossref","first-page":"1s","DOI":"10.1378\/chest.129.1_suppl.1S","article-title":"Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines","volume":"129","author":"Irwin","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.mayocpiqo.2026.100707_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.rmed.2018.06.024","article-title":"New insights in the diagnosis of chronic refractory cough","volume":"141","author":"Good","year":"2018","journal-title":"Respir Med"},{"issue":"11","key":"10.1016\/j.mayocpiqo.2026.100707_bib10","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.4065\/82.11.1350","article-title":"Use of exhaled nitric oxide in predicting response to inhaled corticosteroids for chronic cough","volume":"82","author":"Hahn","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"10.1016\/j.mayocpiqo.2026.100707_bib11","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1056\/NEJMra2309906","article-title":"Unexplained or refractory chronic cough in adults","volume":"392","author":"Irwin","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2026.100707_bib12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-022-00370-w","article-title":"Cough hypersensitivity and chronic cough","volume":"8","author":"Chung","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2026.100707_bib13","doi-asserted-by":"crossref","first-page":"00793","DOI":"10.1183\/23120541.00793-2020","article-title":"Is laryngeal hypersensitivity the basis of unexplained or refractory chronic cough?","volume":"7","author":"Sundar","year":"2021","journal-title":"ERJ Open Res"},{"issue":"162","key":"10.1016\/j.mayocpiqo.2026.100707_bib14","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0127-2021","article-title":"Chronic cough: new insights and future prospects","volume":"30","author":"Morice","year":"2021","journal-title":"Eur Respir Rev"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2026.100707_bib15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.chest.2017.10.016","article-title":"Classification of cough as a symptom in adults and management algorithms: CHEST Guideline and Expert Panel Report","volume":"153","author":"Irwin","year":"2018","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2026.100707_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1378\/chest.15-0423","article-title":"Somatic cough syndrome (previously referred to as psychogenic cough) and tic cough (previously referred to as habit cough) in adults and children: CHEST Guideline and Expert Panel Report","volume":"148","author":"Vertigan","year":"2015","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2026.100707_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1378\/chest.15-0164","article-title":"Assessment of intervention fidelity and recommendations for researchers conducting studies on the diagnosis and treatment of chronic cough in the adult: CHEST Guideline and Expert Panel Report","volume":"148","author":"French","year":"2015","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2026.100707_bib18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/thorax.58.4.339","article-title":"Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)","volume":"58","author":"Birring","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.mayocpiqo.2026.100707_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/17534666211049743","article-title":"Validation of a visual analog scale for assessing cough severity in patients with chronic cough","volume":"15","author":"Martin Nguyen","year":"2021","journal-title":"Ther Adv Respir Dis"},{"issue":"10","key":"10.1016\/j.mayocpiqo.2026.100707_bib20","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jclinepi.2009.09.015","article-title":"A prospective global measure, the Punum Ladder, provides more valid assessments of quality of life than a retrospective transition measure","volume":"63","author":"Fletcher","year":"2010","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"10.1016\/j.mayocpiqo.2026.100707_bib21","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.21037\/jtd-24-705","article-title":"Patient-reported assessments of chronic cough in clinical trials: accessory or primary endpoints?","volume":"16","author":"Mackay","year":"2024","journal-title":"J Thorac Dis"},{"issue":"12","key":"10.1016\/j.mayocpiqo.2026.100707_bib22","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1016\/j.jaip.2023.08.046","article-title":"Patient global impression of severity scale in chronic cough: validation and formulation of symptom severity categories","volume":"11","author":"Rhatigan","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2026.100707_bib23","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.resinv.2024.02.017","article-title":"Prevalence and causes of chronic cough in Japan","volume":"62","author":"Ishiura","year":"2024","journal-title":"Respir Investig"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2026.100707_bib24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12890-017-0496-1","article-title":"Long-term prognosis of chronic cough: a prospective, observational cohort study","volume":"17","author":"Koskela","year":"2017","journal-title":"BMC Pulm Med"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2026.100707_bib25","doi-asserted-by":"crossref","first-page":"00254","DOI":"10.1183\/23120541.00254-2024","article-title":"Prevalence of refractory and unexplained chronic cough in adults treated in cough centre","volume":"10","author":"Kukie\u0142ka","year":"2024","journal-title":"ERJ Open Res"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2026.100707_bib26","doi-asserted-by":"crossref","first-page":"00888","DOI":"10.1183\/23120541.00888-2024","article-title":"Prevalence and burden of possible refractory chronic cough in four European countries","volume":"11","author":"Dom\u00ednguez-Ortega","year":"2025","journal-title":"ERJ Open Res"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2026.100707_bib27","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4168\/aair.2023.15.6.795","article-title":"New insights into refractory chronic cough and unexplained chronic cough: a 6-year ambispective cohort study","volume":"15","author":"Zhang","year":"2023","journal-title":"Allergy Asthma Immunol Res"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2026.100707_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/thoraxjnl-2016-208843","article-title":"Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: a multicentre randomised control trial","volume":"72","author":"Chamberlain Mitchell","year":"2017","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2026.100707_bib29","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1378\/chest.15-1271","article-title":"Pregabalin and speech pathology combination therapy for refractory chronic cough: a randomized controlled trial","volume":"149","author":"Vertigan","year":"2016","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2026.100707_bib30","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/0194599812471817","article-title":"Use of specific neuromodulators in the treatment of chronic, idiopathic cough: a systematic review","volume":"148","author":"Cohen","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"9853","key":"10.1016\/j.mayocpiqo.2026.100707_bib31","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0140-6736(12)60776-4","article-title":"Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Ryan","year":"2012","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.mayocpiqo.2026.100707_bib32","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/thx.2006.064337","article-title":"Efficacy of speech pathology management for chronic cough: a randomised placebo controlled trial of treatment efficacy","volume":"61","author":"Vertigan","year":"2006","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2026.100707_bib33","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.amjmed.2005.10.046","article-title":"Gabapentin in the treatment of intractable idiopathic chronic cough: case reports","volume":"119","author":"Mintz","year":"2006","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.mayocpiqo.2026.100707_bib34","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1097\/01.mlg.0000244377.60334.e3","article-title":"Effectiveness of amitriptyline versus cough suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy","volume":"116","author":"Jeyakumar","year":"2006","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2026.100707_bib35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000029232","article-title":"Treatment of chronic, refractory cough with baclofen","volume":"65","author":"Dicpinigaitis","year":"1998","journal-title":"Respiration"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2026.100707_bib36","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.21037\/jtd-22-1757","article-title":"Pathogenesis and management of gastroesophageal reflux disease-associated cough: a narrative review","volume":"15","author":"Zhang","year":"2023","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.mayocpiqo.2026.100707_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106439","article-title":"Pressure and length of the lower esophageal sphincter as predictive indicators of therapeutic efficacy of baclofen for refractory gastroesophageal reflux-induced chronic cough","volume":"183","author":"Zhu","year":"2021","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2026.100707_bib38","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/apt.15169","article-title":"Randomised clinical trial: gabapentin vs baclofen in the treatment of suspected refractory gastro-oesophageal reflux-induced chronic cough","volume":"49","author":"Dong","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"14","key":"10.1016\/j.mayocpiqo.2026.100707_bib39","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jama.2023.18508","article-title":"Gefapixant for refractory or unexplained chronic cough?","volume":"330","author":"Irwin","year":"2023","journal-title":"JAMA"},{"issue":"10328","key":"10.1016\/j.mayocpiqo.2026.100707_bib40","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0140-6736(21)02348-5","article-title":"Efficacy and safety of gefapixant, a P2X(3) receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials","volume":"399","author":"McGarvey","year":"2022","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.mayocpiqo.2026.100707_bib41","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S2213-2600(19)30471-0","article-title":"Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial","volume":"8","author":"Smith","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2026.100707_bib42","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1164\/rccm.202409-1752OC","article-title":"Camlipixant in refractory chronic cough: a phase 2b, randomized, placebo-controlled trial (SOOTHE)","volume":"211","author":"Smith","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2026.100707_bib43","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.chest.2024.05.015","article-title":"Benefit-risk profile of P2X3 receptor antagonists for treatment of chronic cough: dose-response model-based network meta-analysis","volume":"166","author":"Yamamoto","year":"2024","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2026.100707_bib44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12931-023-02384-8","article-title":"The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial","volume":"24","author":"Friedrich","year":"2023","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2026.100707_bib45","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00439-2019","article-title":"The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised placebo-controlled study","volume":"54","author":"Morice","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.mayocpiqo.2026.100707_bib46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pupt.2019.03.007","article-title":"BLU-5937: a selective P2X3 antagonist with potent anti-tussive effect and no taste alteration","volume":"56","author":"Garceau","year":"2019","journal-title":"Pulm Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2026.100707_bib47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jsmc.2024.02.004","article-title":"Chronic cough and obstructive sleep apnea","volume":"19","author":"Sundar","year":"2024","journal-title":"Sleep Med Clin"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2026.100707_bib48","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12890-022-02222-5","article-title":"Impact of high-risk of obstructive sleep apnea on chronic cough: data from the Korea National Health and Nutrition Examination Survey","volume":"22","author":"Kim","year":"2022","journal-title":"BMC Pulm Med"}],"container-title":["Mayo Clinic Proceedings: Innovations, Quality &amp; Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454826000147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454826000147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:52:01Z","timestamp":1781711521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542454826000147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2542454826000147"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2026.100707","relation":{},"ISSN":["2542-4548"],"issn-type":[{"value":"2542-4548","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When Refractory Is Not the End: Redefining Chronic Cough Through Tertiary Center Evaluation","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings: Innovations, Quality & Outcomes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2026.100707","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research.","name":"copyright","label":"Copyright"}],"article-number":"100707"}}